Decrease of 5-hydroxymethylcytosine in primary cutaneous CD4+ small/medium sized pleomorphic T-cell lymphoproliferative disorder
Abstract Background: Primary cutaneous CD4+ small/medium-sized pleomorphic T-Cell lymphoproliferative disorder (PC-SMTLD) has been considered as a controversial dermatological disease that has been included in cutaneous T-cell lymphoma group, presenting most commonly as a solitary nodule and/or pla...
Main Authors: | Jiahui Hu, Xinyue Zhang, Lihong Zhao, Qiang Zhao, Songmei Geng |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Dermatologia
2024-01-01
|
Series: | Anais Brasileiros de Dermatologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962024000100027&lng=en&tlng=en |
Similar Items
-
Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4+
by: Valeriu Ardeleanu, et al.
Published: (2022-11-01) -
Addendum to “Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab”
by: Rosanne Ottevanger, MD, et al.
Published: (2024-03-01) -
Primary Cutaneous CD4-Positive Small/Medium- Sized Pleomorphic T-Cell Lymphoma Following Heart Transplantation
by: B Shakerian, et al.
Published: (2017-07-01) -
Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination—What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature
by: Francisco Javier De la Torre-Gomar, et al.
Published: (2024-03-01) -
Primary Cutaneous CD30-Positive Lymphoproliferative Disorders—Current Therapeutic Approaches with a Focus on Brentuximab Vedotin
by: Tomasz Stein, et al.
Published: (2024-01-01)